Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the pilot study of Cabozantinib for recurrent or progressive central nervous system tumors in children. This change may reflect new data or findings related to the feasibility and exploratory efficacy of using Cabozantinib for these types of tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:05.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for patients, including age, diagnosis, disease status, and prior therapy requirements. Previously, this section had no information provided.
    Difference
    60%
    Check dated 2024-05-22T21:12:12.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:42:59.000Z thumbnail image

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.